Case Report
ELISA-Based Crossmatching Allowing the Detection of Emerging Donor-Specific Anti-HLA Antibodies through the Use of Stored Donors’ Cell Lysates
Table 2
Results of different antibody detection and specification analyses in comparison with crossmatch-ELISA outcomes all of which exclude an involvement of anti-HLA DSA in a rejection episode of the 48-year-old heart recipient with high probability.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
n.d.: not done; neg.: negative; pos.: positive; PRA%: panel-reactive antibodies %; SD: Single Donor/PRA resolution; analyses for entering the waiting list; analyses at the date of the transplantation; routinely performed posttransplantation analyses; analyses at the date of the clinically proven rejection episode; (AbCr.): after its discontinuation in 2013 the AMS-ELISA was replaced by the highly modified AbCross-ELISA. |